help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zagzag, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zagzag, D.

American Journal of Pathology, Vol 146, 293-309, Copyright © 1995 by American Society for Investigative Pathology


REVIEWS

Angiogenic growth factors in neural embryogenesis and neoplasia

D Zagzag
Department of Pathology, Kaplan Comprehensive Cancer Center, New York University Medical Center, New York.

"Blood vessels have the power to increase within themselves which is according to the necessity whether natural or diseased. As a further proof that this is a general principle, we find that all growing parts are much more vascular than those that are come to their full growth; because growth is an operation beyond the simple support of the part. This is the reason why young animals are more vascular than those that are full grown. This is not peculiar to the natural operation of growth, but applies also to disease and restoration."


This article has been cited by other articles:


Home page
Neuro Oncol DukeHome page
S. Takano, K. Tsuboi, A. Matsumura, and T. Nose
Anti-vascular endothelial growth factor antibody and nimustine as combined therapy: Effects on tumor growth and angiogenesis in human glioblastoma xenografts
Neuro-oncol, January 1, 2003; 5(1): 1 - 7.
[Abstract] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. R. Chinoy, M. M. Graybill, S. A. Miller, C. M. Lang, and G. L. Kauffman
Angiopoietin-1 and VEGF in vascular development and angiogenesis in hypoplastic lungs
Am J Physiol Lung Cell Mol Physiol, July 1, 2002; 283(1): L60 - L66.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
R. E. McLendon, C. J. Wikstrand, M. R. Matthews, R. Al-Baradei, S. H. Bigner, and D. D. Bigner
Glioma-associated Antigen Expression in Oligodendroglial Neoplasms: Tenascin and Epidermal Growth Factor Receptor
J. Histochem. Cytochem., August 1, 2000; 48(8): 1103 - 1110.
[Abstract] [Full Text]


Home page
IOVSHome page
S. Shiose, T. Sakamoto, H. Yoshikawa, Y. Hata, Y. Kawano, T. Ishibashi, H. Inomata, K. Takayama, and H. Ueno
Gene Transfer of a Soluble Receptor of VEGF Inhibits the Growth of Experimental Eyelid Malignant Melanoma
Invest. Ophthalmol. Vis. Sci., August 1, 2000; 41(9): 2395 - 2403.
[Abstract] [Full Text]


Home page
Am. J. Neuroradiol.Home page
P. Kim Nelson, L. T. Masters, D. Zagzag, and P. J. Kelly
Angiographic Abnormalities in Progressive Multifocal Leukoencephalopathy: An Explanation Based on Neuropathologic Findings
AJNR Am. J. Neuroradiol., March 1, 1999; 20(3): 487 - 494.
[Abstract] [Full Text]


Home page
Br J OphthalmolHome page
R. O SCHLINGEMANN and V. W M VAN HINSBERGH
Role of vascular permeability factor/vascular endothelial growth factor in eye disease
Br J Ophthalmol, June 1, 1997; 81(6): 501 - 512.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Society for Investigative Pathology.